Skip to main content
Premium Trial:

Request an Annual Quote

Tekmira Prices Common Stock Offering

Premium

Tekmira Pharmaceuticals said this week that it has priced a public offering of 3.75 million shares of its common stock at $8 a share, for gross proceeds of $30 million.

Tekmira stock closed at $8.82 on Wednesday.

The company said that the underwriters of the offering have also been granted an option to purchase an additional 562,500 shares.

The offering is expected to close on or about Oct. 22.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.